Retaining Excellent Treatment to Significantly Save Operation Costs
By MedTech Outlook | Monday, February 04, 2019
In many countries, regenerative medicine (RM) has been identified as a strategic priority, and thus, a number of initiatives have been launched to enhance innovation. Global RM investment is exponentially increasing. In the coming five years, a wave of new therapies are anticipated, which will increase to $120 billion by 2035 on the global market. RM has expanded to include a wider variety of cell and stem cell therapies such as embryonic and laboratory-grown stem cells. Up to 34 percent of Americans complain of shoulder pain with a significant share of rotating cuffs. This results in 4.5 million doctors’ visits per year and an operation resulting in 1.5 million visits. 56 percent of the population over 45 years has problems with knee and hip, which results in 1 million surgeries every year for knee and hip replacements. Regenerative therapy cures injuries by the growth of new, healthy tissues that can repair damaged tissues fully.
RM is a disruptive innovation designed to change therapy to prevent intractable diseases. It leaves traditional treatment because of their claim to cure rather than just treat chronic conditions, and because new forms of collaboration between therapists and surgeons are needed for clinical delivery. There are, however, concerns about the slow or failure to transpose interruptive RM innovations. In regenerative medicine, FutureHealth Alliance offers the best solutions for prevention. They offer specialized options for arthritis treatment, knee injury, shoulders, back pain, joint preservation, wound treatment, and management of pain. FutureHealth Alliance is dedicated to preventing high-cost surgeries and optimizing health care. A comprehensive health and success plan is provided by the management of chronic patients, diabetes, allergy testing, eye-tracking, and nutrigenomics diet.
Coba Health has partnered with FutureHealth Alliance to provide cost-efficient and affordable options for an expensive, painful knee, hip and backing, PGx and genome testing, treatment of diabetic and chronic diseases and management of medicinal products. FutureHealth Alliance and Coba Health help employers reduce their health and risk costs while improving outcomes. The company was established to help self-supported employers and their personnel, while retaining excellent treatment, to significantly save operation costs. Saving money for companies is their task with a growing, quality-based network of providers. The health services offer transparency, excellence, and integrity, representing over 1.2 million lives.
FutureHealth Alliance is a strategic alliance of innovative patient-focused healthcare providers and technologies, committed to changing today and for the future.